Creabilis raises €15 million as Abbott Biotech Ventures comes on board
This article was originally published in Scrip
Executive Summary
Creabilis has raised €15 million in a series B fundraising led by new investor Abbott Biotech Ventures. The company's largest investor remains Sofinnova Partners, which also participated in the round, joined by existing investors Neomed and private Italian investors.